|
US2021009556A1
|
|
Compound for treating cystic fibrosis
|
|
CN108289869A
|
|
The method for treating pain or fever using the paracetamol dimer of the pharmaceutical active connected by phenolic hydroxyl group
|
|
KR20180080248A
|
|
Ethylene glycol ether of buprenorphine
|
|
TW201725040A
|
|
Use of buprenorphine dimer in the treatment of peripheral neuropathic pain
|
|
TW201726121A
|
|
Methods of treating pain or fever using pharmaceutically active acetaminophen dimers linked through phenolic hydroxyl groups
|
|
SG11201608918SA
|
|
Pharmaceutically active dimers linked through phenolic hydroxyl groups
|
